Publicacions en què col·labora amb Laura Contreras Ruiz (14)

2019

  1. Topical application of TGF-β-activating peptide, KRFK, prevents inflammatory manifestations in the TSP-1-deficient mouse model of chronic ocular inflammation

    International Journal of Molecular Sciences, Vol. 20, Núm. 1

2016

  1. Conjunctival Goblet Cell Function: Effect of Contact Lens Wear and Cytokines

    Eye and Contact Lens, Vol. 42, Núm. 2, pp. 83-90

2015

  1. Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival Cells

    Journal of Ocular Pharmacology and Therapeutics, Vol. 31, Núm. 7, pp. 419-428

2014

  1. CD44 and RHAMM hyaluronan receptors in human ocular surface inflammation

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 252, Núm. 8, pp. 1289-1295

  2. Trefoil factor family peptide 3 (TFF3) is upregulated under experimental conditions similar to dry eye disease and supports corneal wound healing effects in vitro

    Investigative Ophthalmology and Visual Science, Vol. 55, Núm. 5, pp. 3037-3042

2013

  1. A nanomedicine to treat ocular surface inflammation: Performance on an experimental dry eye murine model

    Gene Therapy, Vol. 20, Núm. 5, pp. 467-477

  2. Involvement of corneal epithelial cells in the Th17 response in an in vitro bacterial inflammation model

    Molecular Vision, Vol. 19, pp. 85-99

2012

  1. Hyaluronan receptors in the human ocular surface: A descriptive and comparative study of RHAMM and CD44 in tissues, cell lines and freshly collected samples

    Histochemistry and Cell Biology, Vol. 137, Núm. 2, pp. 165-176

  2. Structural and functional alteration of corneal epithelial barrier under inflammatory conditions

    Current Eye Research, Vol. 37, Núm. 11, pp. 971-981

2011

  1. Drug delivery systems for ophthalmic administration of antiinflammatory agents

    Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry, Vol. 10, Núm. 3, pp. 203-214

  2. Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles

    Molecular Pharmaceutics, Vol. 8, Núm. 5, pp. 1783-1788

  3. Intracellular trafficking of hyaluronic acid-chitosan oligomerbased nanoparticles in cultured human ocular surface cells

    Molecular Vision, Vol. 17, pp. 279-290

2010

  1. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles

    Cornea, Vol. 29, Núm. 5, pp. 550-558

2008

  1. Chitosan-Based Colloidal Systems as Promising Topical Drug Carriers for Ocular Surface Disorders

    PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS